These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28533356)

  • 21. The Emerging Role of Cables1 in Cancer and Other Diseases.
    Huang JR; Tan GM; Li Y; Shi Z
    Mol Pharmacol; 2017 Sep; 92(3):240-245. PubMed ID: 28119482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A putative role for the aryl hydrocarbon receptor (AHR) gene in a patient with cyclical Cushing's disease.
    De Sousa SMC; Manavis J; Feng J; Wang P; Schreiber AW; Scott HS; Torpy DJ
    BMC Endocr Disord; 2020 Jan; 20(1):18. PubMed ID: 31996203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
    Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M
    Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of CABLES1, a cyclin-dependent kinase-interacting protein that inhibits cell cycle progression, results in germline expansion at the expense of oocyte quality in adult female mice.
    Lee HJ; Sakamoto H; Luo H; Skaznik-Wikiel ME; Friel AM; Niikura T; Tilly JC; Niikura Y; Klein R; Styer AK; Zukerberg LR; Tilly JL; Rueda BR
    Cell Cycle; 2007 Nov; 6(21):2678-84. PubMed ID: 17912041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus.
    Huizenga NA; de Lange P; Koper JW; Clayton RN; Farrell WE; van der Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1998 Mar; 83(3):917-21. PubMed ID: 9506748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report.
    Bao XD; Lu L; Zhu HJ; Yao Y; Feng M; Wang RZ; Zhai X; Fu Y; Gong FY; Lu ZL
    BMC Endocr Disord; 2022 Jun; 22(1):152. PubMed ID: 35668434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the EGFR Pathway by HSP90 Is Involved in the Pathogenesis of Cushing's Disease.
    Shen Y; Ji C; Jian X; Zhou J; Zhang Q; Qiao N; Zhang Y; Shou X; Zhou X; Ma Z
    Front Endocrinol (Lausanne); 2020; 11():601984. PubMed ID: 33537004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation.
    Occhi G; Regazzo D; Albiger NM; Ceccato F; Ferasin S; Scanarini M; Denaro L; Cosma C; Plebani M; Cassarino MF; Mantovani G; Stalla GK; Pecori Giraldi F; Paez-Pareda M; Scaroni C
    Endocrinology; 2014 Sep; 155(9):3538-49. PubMed ID: 24926820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cables1 complex couples survival signaling to the cell death machinery.
    Shi Z; Park HR; Du Y; Li Z; Cheng K; Sun SY; Li Z; Fu H; Khuri FR
    Cancer Res; 2015 Jan; 75(1):147-158. PubMed ID: 25361894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of Cushing's disease: an update.
    Perez-Rivas LG; Reincke M
    J Endocrinol Invest; 2016 Jan; 39(1):29-35. PubMed ID: 26208471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR199a-3p regulates P53 by targeting CABLES1 in mouse cardiac c-kit
    Liu J; Wang Y; Cui J; Sun M; Pu Z; Wang C; Du W; Liu X; Wu J; Hou J; Zhang S; Yu B
    Stem Cell Res Ther; 2017 Jun; 8(1):127. PubMed ID: 28583208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRH stimulation improves
    Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
    Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.
    Asuzu DT; Alvarez R; Fletcher PA; Mandal D; Johnson K; Wu W; Elkahloun A; Clavijo P; Allen C; Maric D; Ray-Chaudhury A; Rajan S; Abdullaev Z; Nwokoye D; Aldape K; Nieman LK; Stratakis C; Stojilkovic SS; Chittiboina P
    Cell Rep; 2022 Aug; 40(8):111223. PubMed ID: 36001971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PATHOGENESIS OF CUSHING DISEASE: AN UPDATE ON THE GENETICS OF CORTICOTROPINOMAS.
    Albani A; Perez-Rivas LG; Reincke M; Theodoropoulou M
    Endocr Pract; 2018 Oct; 24(10):907-914. PubMed ID: 30084690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.
    Yamamoto M; Nakao T; Ogawa W; Fukuoka H
    Front Endocrinol (Lausanne); 2021; 12():650791. PubMed ID: 34220707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.
    Gentilin E; Tagliati F; Filieri C; Molè D; Minoia M; Rosaria Ambrosio M; Degli Uberti EC; Zatelli MC
    Endocrinology; 2013 May; 154(5):1690-700. PubMed ID: 23525216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas.
    Tani Y; Inoshita N; Sugiyama T; Kato M; Yamada S; Shichiri M; Hirata Y
    Eur J Endocrinol; 2010 Oct; 163(4):523-9. PubMed ID: 20616110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.